Announced Sun, 29 Jun · 24:24 IST

INTIMATION OF EXTRA-ORDINARY GENERAL MEETING ,SCHEDULED TO BE HELD ON 22 JULY 2025

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kimia Biosciences Ltd has informed the stock exchanges about an Extra-Ordinary General Meeting (EGM) of its shareholders scheduled to be held on 22 July 2025. An EGM is a special meeting called outside the regular annual general meeting cycle, usually to seek shareholder approval on specific urgent or non-routine matters. The detailed agenda and resolutions to be tabled at the meeting would be set out in the notice sent to shareholders. Shareholders and investors should watch for the formal EGM notice to understand the specific items being put to vote.

Likely market impact

EGM intimation itself is a routine compliance disclosure and typically has no immediate impact on the stock price. However, the resolutions tabled at the EGM (such as fund raising, preferential allotments, or changes in capital structure) could be material once the detailed notice is released.